[HTML][HTML] Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
Background & Aims Obesity defined by body mass index (BMI) significantly increases the
risk of hepatocellular carcinoma (HCC). In contrast, not only obesity but also underweight is …
risk of hepatocellular carcinoma (HCC). In contrast, not only obesity but also underweight is …
Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation
Y Kudo, K Tateishi, K Yamamoto, S Yamamoto… - Cancer …, 2012 - Wiley Online Library
Dysregulated DNA methylation followed by abnormal gene expression is an epigenetic
hallmark in cancer. DNA methylation is catalyzed by DNA methyltransferases, and the …
hallmark in cancer. DNA methylation is catalyzed by DNA methyltransferases, and the …
CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity
N Fujiwara, H Nakagawa, K Enooku, Y Kudo, Y Hayata… - Gut, 2018 - gut.bmj.com
Objective Metabolic reprogramming of tumour cells that allows for adaptation to their local
environment is a hallmark of cancer. Interestingly, obesity-driven and non-alcoholic …
environment is a hallmark of cancer. Interestingly, obesity-driven and non-alcoholic …
[HTML][HTML] Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis
S Kawamura, Y Matsushita, S Kurosaki… - The Journal of …, 2022 - Am Soc Clin Investig
Enhanced de novo lipogenesis mediated by sterol regulatory element–binding proteins
(SREBPs) is thought to be involved in nonalcoholic steatohepatitis (NASH) pathogenesis. In …
(SREBPs) is thought to be involved in nonalcoholic steatohepatitis (NASH) pathogenesis. In …
[PDF][PDF] PKCλ/ι loss induces autophagy, oxidative phosphorylation, and NRF2 to promote liver cancer progression
Oxidative stress plays a critical role in liver tissue damage and in hepatocellular carcinoma
(HCC) initiation and progression. However, the mechanisms that regulate autophagy and …
(HCC) initiation and progression. However, the mechanisms that regulate autophagy and …
Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα
K Yamamoto, K Tateishi, Y Kudo, T Sato… - …, 2014 - academic.oup.com
Genetic mutations in pancreatic ductal adenocarcinoma (PDAC) with critical roles have
been well examined. The recent discovery of alterations in genes encoding histone …
been well examined. The recent discovery of alterations in genes encoding histone …
[PDF][PDF] Stromal SOX2 upregulation promotes tumorigenesis through the generation of a SFRP1/2-expressing cancer-associated fibroblast population
H Kasashima, A Duran, A Martinez-Ordoñez… - Developmental cell, 2021 - cell.com
Cancer-associated fibroblasts (CAFs) promote tumor malignancy, but the precise
transcriptional mechanisms regulating the acquisition of the CAF phenotype are not well …
transcriptional mechanisms regulating the acquisition of the CAF phenotype are not well …
[HTML][HTML] Immunomodulation by inflammation during liver and gastrointestinal tumorigenesis and aging
N Nagai, Y Kudo, D Aki, H Nakagawa… - International journal of …, 2021 - mdpi.com
Chronic inflammation is thought to promote tumorigenesis and metastasis by several
mechanisms, such as affecting tumor cells directly, establishing a tumor-supporting …
mechanisms, such as affecting tumor cells directly, establishing a tumor-supporting …
Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression
M Ohta, M Seto, H Ijichi, K Miyabayashi, Y Kudo… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Although colorectal cancer (CRC) progression has been
associated with alterations in KRAS and RAS signaling, not all CRC cells have KRAS gene …
associated with alterations in KRAS and RAS signaling, not all CRC cells have KRAS gene …
Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway
Y Kudo, Y Tanaka, K Tateishi, K Yamamoto… - Journal of …, 2011 - Elsevier
BACKGROUND & AIMS: Some clinical findings have suggested that systemic metabolic
disorders accelerate in vivo tumor progression. Deregulation of the phosphatidylinositol 3 …
disorders accelerate in vivo tumor progression. Deregulation of the phosphatidylinositol 3 …